Cochrane · systematic review · CD011107
Alpha‐2 adrenergic agonists for the prevention of shivering following general anaesthesia
Lewis, SR, Nicholson, A, Smith, AF, et al. · Cochrane Database of Systematic Reviews · 2015 · Cochrane Library
AnaesthesiaAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
3
current version
GRADE rated
1
No studies
2
Included studies
NR
No studies 2 · 66.7%Ungraded 0 · 0%Very low 1 · 33.3%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Alpha‐2 adrenergic agonist compared to placebo/control for the prevention of shivering following general anaesthesia
Population: people with surgical requirement for general anaesthesia
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Shivering Alpha‐2 adrenergic agonist vs placebo/control | RR 0.28 [0.18, 0.43] | 20 studies · 1391 participants | Very low Downgraded: risk of bias, inconsistency, publication bias |
Incidence of core hypothermia ‐ not measured Alpha‐2 adrenergic agonist vs placebo/control | no estimate extracted | NR | No studies |
Participant satisfaction/experience of shivering ‐ not measured Alpha‐2 adrenergic agonist vs placebo/control | no estimate extracted | NR | No studies |